62921-75-9

Basic information

• Product Name: TRI(ETHYLENE GLYCOL) MONOMETHYL ETHER TOSYLATE
• Synonyms: TRI(ETHYLENE GLYCOL) MONOMETHYL ETHER TOSYLATE;Triethylene glycol mono ethyl ether tosylate;Ethanol, 2-[2-(2-ethoxyethoxy)ethoxy]-, 4-methylbenzenesulfonate
• CAS NO: 62921-75-9
• Molecular Formula: C₁₅H₂₄O₆S
• Molecular Weight: 318.39
• Mol File: 62921-75-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: TRI(ETHYLENE GLYCOL) MONOMETHYL ETHER TOSYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TRI(ETHYLENE GLYCOL) MONOMETHYL ETHER TOSYLATE(62921-75-9)
• EPA Substance Registry System: TRI(ETHYLENE GLYCOL) MONOMETHYL ETHER TOSYLATE(62921-75-9)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 62921-75-9(Hazardous Substances Data)

Upstream product

• 112-50-5 monoethyl ether of triethylene glycol 
• 98-59-9 p-toluenesulfonyl chloride 
• 111-77-3 2-(2-methoxyethoxy)ethyl alcohol 
• 7647-01-0 hydrogenchloride 

Downstream Products

• 160680-18-2 4-(1,4,7,10-tetraoxadodecyl)aniline 
• 1073154-01-4 1-{2-[2-(2-ethoxyethoxy)ethoxy]ethoxy}-2-iodobenzene 
• 74654-07-2 2-[2-(2-methoxyethoxy)ethoxy]ethylamine 
• 74654-06-1 2-(2-(2-methoxyethoxy)ethoxy)ethyl azide 
• 1429208-29-6 3,3'-(perfluorocyclopent-1-ene-1,2-diyl)bis(2-(4-(tert-butyl)phenyl)-6-(2-(2-(2-ethoxyethoxy)ethoxy)ethoxy)benzofuran) 
• 1595067-42-7 C₃₉H₇₁BrO₁₆ 
• 1595067-40-5 C₃₉H₇₂O₁₇ 
• 1595067-38-1 C₄₀H₇₂O₁₈ 
• 1595067-36-9 C₂₃H₄₀O₁₀S 
• 1202396-89-1 2-(2-(2-(3,4,5-tris(2-(2-(2-ethoxyethoxy)ethoxy)ethoxy)benzyloxy)ethoxy)ethoxy)ethanol 
• 1104597-89-8 3,4,5-tris(2-(2-(2-ethoxyethoxy)ethoxy)ethoxy)benzyl chloride 
• 1096159-35-1 1-(hydroxymethyl)-3,4,5-tri{2-[2-(2-ethoxyethoxy)ethoxy]ethoxy}benzene 
• 145373-80-4 2-(2-(2-ethoxyethoxy)ethoxy)ethan-1-amine 

Relevant articles and documents

Deep-blue-emitting nanoaggregates from carbazole-based dyes in water

New amphiphilic carbazole-based dyes assemble in water into deep-blue-emitting, highly fluorescent helical aggregates as observed by transmission electron microscopy and atomic force microscopy. Single crystal X-ray diffraction and NMR spectroscopy reveal

Synthesis of a triethylene glycol-capped benzo[1,2-c:4,5-c']bis[2]benzopyran-5,12-dione: A highly soluble dilactone-bridged p-terphenyl with a crankshaft architecture

3,10-Bis(triethylene glycol)benzo[1,2-c:4,5-c']bis[2]benzopyran-5,12-dione has been synthesized as an example of a dilactone-bridged p-terphenyl with a C2h crankshaft architecture that exhibits significant fluorescence. Lactone-bridged rotation

PYRROLO[2,3-B]PYRIDIN DERIVATIVES AS INHIBITORS OF INFLUENZA VIRUS REPLICATION

Provided herein are compounds of Formula A, B or C that can inhibit the replication of influenza viruses, reduce the amount of influenza viruses, and/or treat influenza.

PYRROLOPYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF INFLUENZA VIRUS REPLICATION

Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient a safe and effective amount of a compound represented by any of Formulas l-lll, or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a safe and effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

Glucopyranosyl derivative and application thereof in medicines

The invention relates to a glucopyranosyl derivative used as a sodium-dependent glucose transporter (SGLT) inhibitor, a medicinal composition containing the derivative, and an application of the derivative and the medicinal composition in medicines, and especially relates to the glucopyranosyl derivative represented by formula (I) or a pharmaceutically acceptable salt or all stereoisomers thereof, or the medicinal composition containing the derivative, and a use of the derivative and the medicinal composition in the preparation of medicines for treating diabetes and diabetes related diseases.

MONOMERS AND POLYMERS DERIVED FROM NATURAL PHENOLS

Monomers, polymers and copolymers are provided that incorporate at least one naturally occurring phenolic compound, such as a plant phenol, as well as methods for producing the monomers and polymers. Plant phenols possessing a reactive group in addition t

CONJUGATE OF A PHOTOSENSITISER AND CHITOSAN AND USES THEREOF

The present invention relates to novel chitosan-based conjugates, e.g. nanocarriers, comprising a derivative of the biocompatible polymer chitosan conjugated to a photosensitising agent, and uses thereof in photochemical internalisation (PCI) and photodynamic therapy (PDT). The invention also relates to the use of the novel conjugates of the invention in treatment or prevention of diseases, particularly cancer, and for vaccination purposes.

Fullerene derivatives with increased dielectric constants

The invention of new organic materials with high dielectric constants is of extreme importance for the development of organic-based devices such as organic solar cells. We report on a synthetic way to increase the dielectric constant of fullerene derivati

Frame-guided assembly of vesicles with programmed geometry and dimensions

In molecular self-assembly molecules form organized structures or patterns. The control of the self-assembly process is an important and challenging topic. Inspired by the cytoskeletal-membrane protein lipid bilayer system that determines the shape of euk